Institution Directory

Clinical trials at NYU Langone Health

Sites in New York, NY

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 8:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1145

Shown on this page

Current sort

Stored official records

Conditions: Bipolar I Disorder, Depression
Interventions: Aripiprazole/Escitalopram combination, Cariprazine, Lurasidone, Quetiapine; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2,726 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 17
States / cities: Birmingham, Alabama • Bloomington, Indiana • Baltimore, Maryland + 13 more

Conditions: Prostate Cancer
Interventions: Bicalutamide, Darolutamide, GnRH Agonist, Radiation Therapy; Drug · Radiation
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 11
States / cities: Stamford, Connecticut • Boston, Massachusetts • Milford, Massachusetts + 6 more

Conditions: Patellofemoral Osteoarthritis
Interventions: LIFT Implant, Tibial Tubercle Osteotomy; Device · Other
Lead sponsor: ZKR Orthopedics Inc; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 5
States / cities: La Mesa, California • New York, New York • Columbus, Ohio + 1 more

Conditions: Advanced Ovarian Cancer, BRCA Mutation, Complete Response, FIGO Stage III-IV, First Line Platinum Chemotherapy, Newly Diagnosed, Partial Response
Interventions: Olaparib 300mg tablets; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years · Female only
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2028
U.S. locations: 81
States / cities: Huntsville, Alabama • Anchorage, Alaska • Phoenix, Arizona + 63 more

Conditions: Hypertension
Interventions: Remote Patient Monitoring (RPM)-enabled Community Health Worker (CHW) Support; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Transplantation
Interventions: Belatacept, Corticosteroid, Mycophenolate Mofetil, Tacrolimus; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: New York, New York

Conditions: Kidney Tumor, Renal Cancer
Interventions: Decision Aid (DA) Web Tool, Institutional Pamphlet; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Kidney Transplantation in Highly Sensitized Patients
Interventions: Best available treatment administered in the ConfIdeS study, Imlifidase administered in the ConfIdeS study; Other · Drug
Lead sponsor: Hansa Biopharma AB; Industry
Eligibility: Not listed
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 14
States / cities: Birmingham, Alabama • Los Angeles, California • Chicago, Illinois + 9 more

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Interventions: Biospecimen Collection, Carboplatin, Cyclophosphamide, Docetaxel, Doxorubicin, Paclitaxel, Pembrolizumab, Quality-of-Life Assessment, Questionnaire Administration, Surgical Procedure; Procedure · Drug · Biological + 1 more
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 2,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 955
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 654 more

Conditions: Covid19
Interventions: Questionnaires; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Crohn's Disease
Interventions: Magnetic Resonance Imaging (MRI) or Magnetic Resonance Enterography (MRE); Diagnostic Test
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 10 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Rochester, Minnesota • New York, New York

Conditions: Intraductal Papillary Mucinous Neoplasm
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Timeline: 2025
U.S. locations: 8
States / cities: Phoenix, Arizona • Baltimore, Maryland • Boston, Massachusetts + 4 more

About this NYU Langone Health institution page

What this page lists: ClinicalTrials.gov records that list NYU Langone Health in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at NYU Langone Health

Filter and sort this campus

Stored official records

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

INTREPId (INTermediate Risk Erection PreservatIon Trial)

Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients

Belatacept in De Novo Heart Transplantation

Decision Aid (DA) for Renal Patients

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

COVID-19 Survivorship Registry

Helmsley 3.0: Abbreviated MRE

Intent of Surgery for IPMN

About this NYU Langone Health institution page